Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study
Irene Cassaniti, Federica Bergami, Elena Percivalle, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 301.e1-301.e8
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Maren Schubert, Federico Bertoglio, Stephan Steinke, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
Yacine Maringer, Annika Nelde, Sarah M. Schroeder, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 61
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
Linda Petrone, Andrea Picchianti Diamanti, Gian Domenico Sebastiani, et al.
International Journal of Infectious Diseases (2022) Vol. 121, pp. 24-30
Open Access | Times Cited: 29
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study
Paolo Corradini, Chiara Agrati, Giovanni Apolone, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e426-e438
Open Access | Times Cited: 29
T cell receptor usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells
Ulrik Fahnøe, Shan Feng, Alexander P. Underwood, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Sex, Age, and Ethnic Background Shape Adaptive Immune Responses Induced by the SARS-CoV-2 mRNA Vaccine
Jie Bai, Asako Chiba, Goh Murayama, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals
Evangelos Terpos, Vangelis Karalis, Ioannis Ntanasis‐Stathopoulos, et al.
Life (2021) Vol. 11, Iss. 10, pp. 1077-1077
Open Access | Times Cited: 29
Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals
Evangelos Terpos, Vangelis Karalis, Ioannis Ntanasis‐Stathopoulos, et al.
HemaSphere (2021) Vol. 6, Iss. 1, pp. e677-e677
Open Access | Times Cited: 23
Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers
Louise Benning, Christian Morath, Marie Bartenschlager, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 7, pp. 1024.e7-1024.e12
Open Access | Times Cited: 16
Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children
Alessandra Ricciardi, Paola Zelini, Irene Cassaniti, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 905-909
Open Access | Times Cited: 12
Human cytomegalovirus (HCMV) long-term shedding and HCMV-specific immune response in pregnant women with primary HCMV infection
Chiara Fornara, Federica Zavaglio, Milena Furione, et al.
Medical Microbiology and Immunology (2022) Vol. 211, Iss. 5-6, pp. 249-260
Closed Access | Times Cited: 11
Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19–Convalescent Individuals
Joanna Luczkowiak, Nuria Labiod, Gonzalo Alonso Rivas, et al.
The Journal of Infectious Diseases (2021) Vol. 225, Iss. 11, pp. 1905-1908
Open Access | Times Cited: 15
Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing
Kelly O’Shea, Charles F. Schuler, Jesse Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Association between Vitamin D Serum Levels and Immune Response to the BNT162b2 Vaccine for SARS-CoV-2
Paola Zelini, Piera d’Angelo, Emanuele Cereda, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1993-1993
Open Access | Times Cited: 9
SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
Jesús Fernando García-Cruces-Méndez, Luís Corral-Gudino, María Piedad Del-Amo-Merino, et al.
European Journal of Internal Medicine (2022) Vol. 97, pp. 113-115
Open Access | Times Cited: 7
Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital
Josè Camilla Sammartino, Irene Cassaniti, Alessandro Ferrari, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 703-703
Open Access | Times Cited: 7
Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant
Irene Cassaniti, Federica Bergami, Francesca Arena, et al.
Microorganisms (2021) Vol. 9, Iss. 12, pp. 2622-2622
Open Access | Times Cited: 10
Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer
Antonio Giovanni Solimando, Max Bittrich, Endrit Shahini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8746-8746
Open Access | Times Cited: 3
An overview of SARS-CoV-2 variants circulating in the 2020–2022 period in Lombardy
Federica Giardina, Guglielmo Ferrari, Federica Zavaglio, et al.
Diagnostic Microbiology and Infectious Disease (2023) Vol. 107, Iss. 4, pp. 116070-116070
Closed Access | Times Cited: 3
Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
Jin Wang, Cheng Guo, Lin Cai, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 7
mRNA BNT162b Vaccine Elicited Higher Antibody and CD4+ T-Cell Responses than Patients with Mild COVID-19
Federica Zavaglio, Irene Cassaniti, Josè Camilla Sammartino, et al.
Microorganisms (2022) Vol. 10, Iss. 6, pp. 1250-1250
Open Access | Times Cited: 5
COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS
Federica Pulvirenti, Eva Piano Mortari, Carolina Putotto, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 1, pp. 292-305.e2
Open Access | Times Cited: 5
Neutralization assays for SARS-CoV-2: Implications for assessment of protective efficacy of COVID-19 vaccines
Labanya Mukhopadhyay, Nivedita Gupta, Pragya D. Yadav, et al.
The Indian Journal of Medical Research (2022) Vol. 155, Iss. 1, pp. 105-122
Open Access | Times Cited: 4
Performance of Whole Blood Stimulation Assays for the Quantification of SARS-CoV-2 Specific T-Cell Response: A Cross-Sectional Study
Federica Bergami, Francesca Arena, Eleonora Francesca Pattonieri, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1509-1509
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top